C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 76 filers reported holding C4 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $133,246 | -12.4% | 48,453 | 0.0% | 0.00% | – |
| Q1 2023 | $152,142 | -46.8% | 48,453 | 0.0% | 0.00% | – |
| Q4 2022 | $285,873 | -30.9% | 48,453 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $414,000 | -0.5% | 48,453 | -12.1% | 0.00% | – |
| Q2 2022 | $416,000 | -84.0% | 55,153 | -48.5% | 0.00% | -100.0% |
| Q1 2022 | $2,600,000 | -24.1% | 107,153 | +0.8% | 0.00% | -33.3% |
| Q4 2021 | $3,425,000 | -23.2% | 106,353 | +6.6% | 0.00% | -40.0% |
| Q3 2021 | $4,457,000 | +7.8% | 99,753 | +4.1% | 0.01% | +25.0% |
| Q2 2021 | $4,135,000 | +68.0% | 95,853 | +44.0% | 0.00% | +33.3% |
| Q1 2021 | $2,462,000 | +370.7% | 66,553 | +321.7% | 0.00% | +200.0% |
| Q4 2020 | $523,000 | – | 15,781 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $39,840,000 | 3.87% |
| Paradigm Biocapital Advisors LP | 499,496 | $12,118,000 | 3.20% |
| Cypress Point Wealth Management, LLC | 118,573 | $2,877,000 | 2.92% |
| COMMODORE CAPITAL LP | 481,094 | $11,671,000 | 2.61% |
| Nextech Invest Ltd. | 375,857 | $9,118,000 | 2.60% |
| RTW INVESTMENTS, LP | 4,531,982 | $109,946,000 | 2.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 362,528 | $8,795,000 | 1.24% |
| Perceptive Advisors | 2,082,723 | $50,526,000 | 1.01% |
| CLOUGH CAPITAL PARTNERS L P | 356,181 | $8,641,000 | 0.66% |
| HighVista Strategies LLC | 34,760 | $843,000 | 0.54% |